ArticlebioRxiv : the preprint server for biology2026
Serum metabolic signatures of cognitive resilience in a longitudinal aging cohort.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Aging is typically accompanied by a progressive decline in cognitive function, yet some individuals maintain exceptional cognitive performance, even across the transition from middle to older age, defining exceptional cognitive resilience. While existing measures of resilience primarily rely on clinical assessments, its molecular determinants and early predictive markers remain poorly understood. Here, we performed untargeted LC-MS/MS profiling of longitudinal serum samples to identify metabolic signatures associated with cognitive resilience, which was established based on cognitive tests conducted over 28 years in a cohort of 237 participants. We observed associations across multiple chemical classes, including carnitines, glutamine conjugates, phosphocholines, as well as diet- and drug-derived metabolites. Chemical class-specific analyses revealed distinct metabolic profiles, including predominantly negative associations of medium-chain acylcarnitines with cognitive resilience, increased accumulation of glucuronide conjugates in individuals with low cognitive resilience, altered metabolism of the antihypertensive drug, metoprolol, and elevated levels of dietary compounds such as piperine and lutein in individuals with high cognitive resilience. By leveraging public metabolomics data, we further contextualized the metabolic signatures with respect to their organ specificity, microbial origin, and disease associations. Collectively, these metabolic features, including several previously underexplored compounds, represent promising candidates for functional characterization in mechanisms of aging biology and provide mechanistic insights into the molecular basis of cognitive resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.